Literature DB >> 1496816

The distribution and some pharmacokinetic parameters of ivermectin in pigs.

E W Scott1, Q A McKellar.   

Abstract

Ivermectin was injected subcutaneously into five pigs at the usual dose rate of 300 micrograms/kg and found to distribute well to all tissues and body fluids which were sampled 24 h post-injection. Ivermectin was detected in the contents and mucus at all levels of the gastrointestinal tract. The drug was excreted in bile, with high concentrations of the drug in the intestines and faeces. High concentrations of ivermectin were measured in skin, ears and ear wax, suggesting that the drug should be effective in the treatment of ectoparasitic infestations, particularly ear mites. The high lipid solubility of the drug may explain the high concentrations found in ear wax and skin. Ivermectin was also detected in the body fluids and tissues of an untreated pig penned with the treated animals. Direct contact appeared to be necessary for transfer of ivermectin from the treated to the untreated pig but coprophagia or urine drinking is a possible explanation. The pharmacokinetics of ivermectin administered subcutaneously at a dose rate of 300 micrograms/kg to six pigs were studied. There was marked individual variation in the pharmacokinetics of ivermectin. In one pig the area under the plasma concentration-time curve was particularly high. This may reflect individual variation in uptake and excretion of the drug. The mean elimination half-life of the drug was 35.2 h, suggesting that the drug is cleared slowly from pigs with drug detectable in plasma for 6-10 days. This persistence should allow a short period of protection before re-infection with parasites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496816     DOI: 10.1007/bf01839011

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  6 in total

1.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

2.  The pharmacokinetics of ivermectin after oral and subcutaneous administration to sheep and horses.

Authors:  S E Marriner; I McKinnon; J A Bogan
Journal:  J Vet Pharmacol Ther       Date:  1987-06       Impact factor: 1.786

3.  Pharmacokinetic studies of ivermectin: effects of formulation.

Authors:  P K Lo; D W Fink; J B Williams; J Blodinger
Journal:  Vet Res Commun       Date:  1985-09       Impact factor: 2.459

4.  Normal phase liquid chromatographic determination of nanogram quantities of ivermectin in cattle blood or plasma.

Authors:  H J Schnitzerling; J Nolan
Journal:  J Assoc Off Anal Chem       Date:  1985 Jan-Feb

5.  The pharmacodynamics of ivermectin in sheep and cattle.

Authors:  J A Bogan; Q A McKellar
Journal:  J Vet Pharmacol Ther       Date:  1988-09       Impact factor: 1.786

6.  Pharmacokinetics of ivermectin administered intravenously to cattle.

Authors:  P K Wilkinson; D G Pope; F P Baylis
Journal:  J Pharm Sci       Date:  1985-10       Impact factor: 3.534

  6 in total
  6 in total

1.  Ivermectin in senegalese peulh sheep: influence of sex on plasma disposition.

Authors:  T Bengone Ndong; Y Kane; E H M Diouf; M Alvinerie
Journal:  Vet Res Commun       Date:  2007-01-27       Impact factor: 2.459

2.  Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications.

Authors:  G V Ullio Gamboa; S D Palma; A Lifschitz; M Ballent; C Lanusse; C Passirani; J P Benoit; D A Allemandi
Journal:  Parasitol Res       Date:  2016-02-06       Impact factor: 2.289

3.  Screening for an ivermectin slow-release formulation suitable for malaria vector control.

Authors:  Carlos Chaccour; Ángel Barrio; Ana Gloria Gil Royo; Diego Martinez Urbistondo; Hannah Slater; Felix Hammann; Jose Luis Del Pozo
Journal:  Malar J       Date:  2015-03-05       Impact factor: 2.979

4.  Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.

Authors:  Carlos J Chaccour; Felix Hammann; Marta Alustiza; Sandra Castejon; Brian B Tarimo; Gloria Abizanda; Ángel Irigoyen Barrio; Helena Martí Soler; Rafael Moncada; José Ignacio Bilbao; Azucena Aldaz; Marta Maia; José Luis Del Pozo
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

5.  Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.

Authors:  Charlotte Bernigaud; Fang Fang; Katja Fischer; Anne Lespine; Ludwig Serge Aho; Dominique Dreau; Andrew Kelly; Jean-François Sutra; Francis Moreau; Thomas Lilin; Françoise Botterel; Jacques Guillot; Olivier Chosidow
Journal:  PLoS Negl Trop Dis       Date:  2016-10-12

6.  Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation.

Authors:  Carlos J Chaccour; Kija Ngha'bi; Gloria Abizanda; Angel Irigoyen Barrio; Azucena Aldaz; Fredros Okumu; Hannah Slater; Jose Luis Del Pozo; Gerry Killeen
Journal:  Parasit Vectors       Date:  2018-05-04       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.